Using video capsules to examine patients with Lynch Syndrome
Official title: Video Capsule Examination in Patients With Lynch and Other Cancer-predisposition Syndromes - a Proof-of-concept Study for Obtaining Data to Support the Development of Machine Learning Algorithms to Detect Early Cancers
Run by Royal Marsden NHS Foundation Trust · NCT06712095 · Data updated 2026-11-12
This study is testing whether video capsules can be a good alternative to regular colonoscopies for people with Lynch Syndrome to help improve cancer screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Royal Marsden NHS Foundation Trust Academic / other |
| Locations | 1 site (London, (Select)) |
| Status | Recruiting |
| Started | March 4, 2024 |
| Main results expected | October 31, 2025 |
| Study ends | October 31, 2025 |
| Registry record updated | December 5, 2024 |
| Trial ID | NCT06712095 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old who are carriers of specific pathogenic variants associated with cancer predisposition and have not undergone previous colon or rectal surgery.
✕Probably not a fit
Patients with extensive bowel surgery or those with active cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the feasibility of using video capsule examinations as an alternative to traditional colonoscopy for patients with Lynch Syndrome and other cancer predisposition syndromes. By obtaining paired images from both colonoscopies and video capsules, the researchers intend to develop an AI algorithm that can assist clinicians in interpreting the images more efficiently. The study will assess the willingness of patients to participate and the technical ability to gather usable data from these paired examinations. The ultimate goal is to enhance access to colorectal cancer surveillance for at-risk patients.
Why it matters
Potential benefit: If successful, this approach could significantly improve colorectal cancer surveillance for patients with Lynch Syndrome and related conditions.
How similar studies have gone: While the use of video capsules is gaining traction, this specific approach of pairing it with AI analysis for Lynch Syndrome patients is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 18 years old with no active cancer * No previous resection of the colon and/or rectum * Carriers of a pathogenic/likely pathogenic variant in any of the following cancer-predisposition genes: Lynch syndrome (MLH1, MSH2, MSH6, PMS2), APC (FAP syndrome); biallelic MUTYH; STK11 (Peutz-Jeghers syndrome); PTEN, CDH1, CHEK2, TP53, BMPR1A and SMAD4 (Juvenile polyposis syndrome) * Able to consent to the study and undergo colonoscopy. Exclusion Criteria: * Extensive surgery which poses a high risk of video-capsule blockage or narrowing of the bowel due to extensive tumour. Extensive surgery implies any removal of large portions of the small or large bowel that might cause a narrowing (stricture) in the digestive tract. * Previous irradiation to abdomen or pelvis (risk for small bowel obstruction) * Carriers of a variant associated with reduced penetrance (in the view of a geneticist) or a variant of uncertain significance. * Patients with a PS of 3 or 4 and/or mobility issues * Pregnancy * Pacemaker or internal electro-medical device (artificial heart valve, cochlear implant or an internal electromedical device). * Insulin-dependent diabetes * Patients who require deep sedation for colonoscopy
Where it's running
-
The Royal Marsden NHS Foundation Trust
London, (Select), United Kingdom Recruiting
Study contacts
- Principal investigator: Richard Lee, PhD — Royal Marsden NHS Foundation Trust
- Study coordinator: Elena Cojocaru, MD
- Email: elena.cojocaru@nhs.net
- Phone: +44 20 7808 2603
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
-
Increasing Genetic Testing for Families at Risk of Cancer
This study is testing a new way to encourage families at risk of cancer to get genetic testing by having healthcare providers reach out directly to them instead of relying on patients to share their results.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
-
Capsule camera screening of the small intestine for people with Lynch syndrome
This project looks back at past small-bowel capsule endoscopy exams to see if they detect precancerous lesions or early cancer in people with Lynch syndrome.
-
Liquid biopsy and machine learning to detect early colorectal cancer, advanced adenomas, Lynch-related cancers, and residual disease
This project will test a blood-based liquid biopsy that uses microRNA signals and machine learning to detect colorectal cancer, advanced adenomas, Lynch-associated cancers, and molecular residual disease in people who have a colonoscopy.
-
Cutting down ultra-processed foods for people at high cancer risk
This project tests whether using the Open Food Facts smartphone app alongside nutrition education helps adults at high risk of cancer eat fewer ultra-processed foods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.